Navigation Links
Essilor Steps Up its Development in Eastern Europe
Date:9/9/2008

CHARENTON-LE-PONT, France, September 10 /PRNewswire-FirstCall/ -- Essilor is pursuing its growth strategy in Eastern Europe's markets by acquiring a majority stake in Omega Optix. The company is a leading operator in the Czech Republic and Slovakia, where its prescription laboratories generate total revenue of more than EUR10 million.

In addition to ensuring the long-term viability of a recognized market player, the acquisition will enable Essilor to offer local customers an alternative lineup of products and services, thereby driving fast growth in a rapidly developing market.

The current Omega Optix management team will remain in place and continue to operate the company independently.

-----------------------

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Essilor(R) and Definity(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 270 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF:FP

------------------------

Investor Relations and Financial Communications

Veronique Gillet - Sebastien Leroy

Phone: +33(0)1-49-77-42-16

http://www.essilor.com


'/>"/>
SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Essilor - First-Half 2008 Revenue
2. Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
3. Essilors 2008 First-Quarter Report
4. Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
5. Essilor : 2007 Results
6. Essilor Enters Bulgarian Market
7. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
8. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
9. 1 step back ... 2 steps forward
10. Five Steps for Staying in Financial Control with Long-Term Disability
11. AHIMA Supports CMS Steps to Adopt ICD-10 Upgrades
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology: